W1186 CARD15/NOD2 Mediates Susceptibility to Yersinia Pseudotuberculosis
Ulrich Meinzer(Assistance Publique – Hôpitaux de Paris), Ghislaine Sterkers(Délégation Paris 7), Fabrice Chareyre(Inserm), Corinne Alberti(Inserm), Frédérick Barreau(Université Toulouse III - Paul Sabatier), Sophie Esmiol-Welterlin(Centre National de la Recherche Scientifique), Stéphane Bonacorsi(Inserm), Michiko Niwa‐Kawakita(Centre National de la Recherche Scientifique), D. Berrebi, Monique Dussaillant(Inserm)
Cited by 0
Related Papers
Using and Reporting the Delphi Method for Selecting Healthcare Quality Indicators: A Systematic Review
|PLoS ONE|2011|2k
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
|Intensive Care Medicine|2001|984
Optimization of Initial Tacrolimus Dose Using Pharmacogenetic Testing
|Clinical Pharmacology & Therapeutics|2010|363
Bacteria-derived long chain fatty acid exhibits anti-inflammatory properties in colitis
|Gut|2020|229
Systemic Inflammatory Response and Progression to Severe Sepsis in Critically Ill Infected Patients
|American Journal of Respiratory and Critical Care Medicine|2004|195